chrX-154030710-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_Strong
The NM_001110792.2(MECP2):c.1154C>A(p.Ser385*) variant causes a stop gained change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000055 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
MECP2
NM_001110792.2 stop_gained
NM_001110792.2 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 3.90
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.229 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.1154C>A | p.Ser385* | stop_gained | 3/3 | ENST00000453960.7 | NP_001104262.1 | |
MECP2 | NM_004992.4 | c.1118C>A | p.Ser373* | stop_gained | 4/4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960.7 | c.1154C>A | p.Ser385* | stop_gained | 3/3 | 1 | NM_001110792.2 | ENSP00000395535.2 | ||
MECP2 | ENST00000303391.11 | c.1118C>A | p.Ser373* | stop_gained | 4/4 | 1 | NM_004992.4 | ENSP00000301948.6 | ||
MECP2 | ENST00000407218 | c.*490C>A | 3_prime_UTR_variant | 4/4 | 5 | ENSP00000384865.2 | ||||
MECP2 | ENST00000628176 | c.*490C>A | 3_prime_UTR_variant | 5/5 | 3 | ENSP00000486978.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 2AN: 110268Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32468 FAILED QC
GnomAD3 genomes
AF:
AC:
2
AN:
110268
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32468
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000169 AC: 3AN: 177404Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64180
GnomAD3 exomes
AF:
AC:
3
AN:
177404
Hom.:
AF XY:
AC XY:
0
AN XY:
64180
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000548 AC: 6AN: 1095368Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 361304
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
6
AN:
1095368
Hom.:
Cov.:
35
AF XY:
AC XY:
0
AN XY:
361304
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000181 AC: 2AN: 110268Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32468
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
110268
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 17, 2018 | Variant summary: MECP2 c.1118C>A (p.Ser373X) results in a premature termination codon, predicted to cause a truncation of the C-terminal segment of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele (described as ChrX:153296161G>T) was found at a frequency of 1.7e-05 in 174031 control chromosomes (in gnomAD), however this nucleotide change might occur as a part of a complex variant with two other missense variants (c.1115A>C and c.1117T>C) that would translate into a different protein level change, therefore these data might not be reliable for assessing variant frequency. Although the pattern of reads in the gnomAD database indicates a complex origin, the possibility of this variant occuring in isolation in patients with Rett syndrome cannot be entirely ruled out. Furthermore, a different nucleotide change (c.1118C>G) resulting in a variant described identically at the protein level as p.Ser373X, has been reported in the literature in an individual affected with either classic or a variant form of Rett Syndrome (Smeets 2009 cross references with HGMD database). In this study, the authors report that complete data were obtained on 103 RTT females clinically diagnosed between 1983 and 2003 according to the international diagnostic criteria for classic and variant RTT. However the specific phenotype of the patient harboring p.Ser373X was not specified. The authors of the study concluded that 'late' truncating mutations in the C-terminal segment develop differently in the long term and remain milder far into adult life. As this publication does not specify the exact nucleotide level change observed in this patient and does not provide any information about other variants in the MECP2 gene present in this individual, it does not provide unequivocal conclusions about association of the variant of interest (namely, c.1118C>A) with either classic or variant Rett Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as a variant of uncertain clinical significance (VUS). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at